- Lexicon Pharmaceuticals (NASDAQ:LXRX -8.4%) Q1 results: Revenues: $12.5M; R&D Expense: $37M (+77.0%); SG&A: $8.4M (+47.4%); Operating Loss: ($33.9M) (-27.9%); Net Loss: ($34.9M) (-24.2%); Loss Per Share: ($0.34) (-25.9%); Quick Assets: $477.1M (-8.5%).
- No guidance given.
Lexicon Pharmaceuticals Q1 net loss worsens 24%
Recommended For You
More Trending News
About LXRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
LXRX | - | - |
Lexicon Pharmaceuticals, Inc. |